Feb 04, 2020 / 01:10PM GMT
Martin Patrick Murphy - Syncona Limited - CEO of Syncona Investment Management Ltd.
Thank you, Elisa. So since foundation in 2012, Syncona's business has been founding and building innovative life science companies based on exceptional basic life science research. And really, the driver for the creation of the Syncona with the Wellcome Trust back in 2012 was really the realization that the U.K. had a globally competitive basic research base, but that we were not building companies at the scale you would expect, given the size and quality of that research base. That was the real role that we wanted Syncona to play. And in the last 7 years, we think we've made substantial progress in achieving that.
So today, we're going to set out for you the vision we have for the future and the strategy by which we're going to seek to achieve that. That will be a presentation from myself, and then I'll pass to Chris Hollowood, a key member of our team, the Chief Investment Officer, who will talk through the individual portfolio of companies.
After that session, we'll open and we'll have some questions,
Syncona Ltd Corporate Analyst Meeting Transcript
Feb 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers